Cambridge Investment Research Advisors, Inc. Tandem Diabetes Care Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 23,953 shares of TNDM stock, worth $493,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,953
Previous 13,667
75.26%
Holding current value
$493,910
Previous $580,000
48.79%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding TNDM
# of Institutions
346Shares Held
70.9MCall Options Held
3.11MPut Options Held
181K-
Black Rock Inc. New York, NY11.1MShares$229 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.44MShares$153 Million0.0% of portfolio
-
State Street Corp Boston, MA2.77MShares$57 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.72MShares$56.2 Million1.47% of portfolio
-
Gw&K Investment Management, LLC Boston, MA2.12MShares$43.8 Million0.65% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $1.32B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...